Cargando…
Teaching an Old Drug New Tricks: Dexamethasone as an In Vivo Inhibitor of Glioblastoma Dispersal
Identifying drugs that can mitigate dispersal of glioblastoma cells, particularly after patients undergo radiotherapy and concomitant chemotherapy, may increase the length of time to recurrence and improve overall survival. Previous studies have shown that dexamethasone (Dex), a drug currently used...
Autores principales: | Carminucci, Arthur, Tejero, Rut, Huang, Yong, Danish, Shabbar, Friedel, Roland H, Foty, Ramsey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243068/ https://www.ncbi.nlm.nih.gov/pubmed/32455066 http://dx.doi.org/10.7759/cureus.7749 |
Ejemplares similares
-
Dexamethasone-mediated inhibition of Glioblastoma neurosphere dispersal in an ex vivo organotypic neural assay
por: Meleis, Ahmed M., et al.
Publicado: (2017) -
Volumetric Trends Associated with MR-guided Stereotactic Laser Amygdalohippocampectomy in Mesial Temporal Lobe Epilepsy
por: Carminucci, Arthur, et al.
Publicado: (2018) -
Dexamethasone-Mediated Upregulation of Calreticulin Inhibits Primary Human Glioblastoma Dispersal Ex Vivo
por: Nair, Mohan, et al.
Publicado: (2018) -
Radiographic Trends for Infield Recurrence After Radiosurgery for Cerebral Metastases
por: Carminucci, Arthur, et al.
Publicado: (2020) -
Plexin-B2 facilitates glioblastoma infiltration by modulating cell biomechanics
por: Huang, Yong, et al.
Publicado: (2021)